Drug Shortage Report for SANDOZ TRAVOPROST
Report ID | 111347 |
Drug Identification Number | 02413167 |
Brand name | SANDOZ TRAVOPROST |
Common or Proper name | Travoprost |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TRAVOPROST |
Strength(s) | 0.004% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ml btl |
ATC code | S01EE |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2020-04-03 |
Estimated end date | 2020-06-19 |
Actual end date | 2020-04-28 |
Shortage status | Resolved |
Updated date | 2020-05-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-05-04 | French | Compare |
v5 | 2020-05-04 | English | Compare |
v4 | 2020-04-27 | French | Compare |
v3 | 2020-04-27 | English | Compare |
v2 | 2020-04-07 | French | Compare |
v1 | 2020-04-07 | English | Compare |
Showing 1 to 6 of 6